Pieris Pharmaceuticals Inc (PIRS)
11.93
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
11.70
-0.23
(-1.93%)
After-Hours: 20:00
Pieris Pharmaceuticals Price to Book Value: 0.5514 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.5514 |
| April 24, 2024 | 0.5514 |
| April 23, 2024 | 0.5546 |
| April 22, 2024 | 0.5402 |
| April 19, 2024 | 0.5361 |
| April 18, 2024 | 0.574 |
| April 17, 2024 | 0.5809 |
| April 16, 2024 | 0.6064 |
| April 15, 2024 | 0.6286 |
| April 12, 2024 | 0.635 |
| April 11, 2024 | 0.6522 |
| April 10, 2024 | 0.6556 |
| April 09, 2024 | 0.6722 |
| April 08, 2024 | 0.64 |
| April 05, 2024 | 0.6352 |
| April 04, 2024 | 0.6341 |
| April 03, 2024 | 0.6441 |
| April 02, 2024 | 0.6581 |
| April 01, 2024 | 0.6914 |
| March 28, 2024 | 0.6774 |
| March 27, 2024 | 0.7162 |
| March 26, 2024 | 0.6951 |
| March 25, 2024 | 0.6718 |
| March 22, 2024 | 0.7395 |
| March 21, 2024 | 0.7391 |
| Date | Value |
|---|---|
| March 20, 2024 | 0.7765 |
| March 19, 2024 | 0.7968 |
| March 18, 2024 | 0.7765 |
| March 15, 2024 | 0.6249 |
| March 14, 2024 | 0.6323 |
| March 13, 2024 | 0.6445 |
| March 12, 2024 | 0.6323 |
| March 11, 2024 | 0.6286 |
| March 08, 2024 | 0.6655 |
| March 07, 2024 | 0.6578 |
| March 06, 2024 | 0.6252 |
| March 05, 2024 | 0.636 |
| March 04, 2024 | 0.6282 |
| March 01, 2024 | 0.6397 |
| February 29, 2024 | 0.6104 |
| February 28, 2024 | 0.6289 |
| February 27, 2024 | 0.5938 |
| February 26, 2024 | 0.6138 |
| February 23, 2024 | 0.6012 |
| February 22, 2024 | 0.5964 |
| February 21, 2024 | 0.6289 |
| February 20, 2024 | 0.6252 |
| February 16, 2024 | 0.5775 |
| February 15, 2024 | 0.5868 |
| February 14, 2024 | 0.5731 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.404
Minimum
Jun 30 2023
14.69
Maximum
Jul 30 2019
4.117
Average
3.634
Median
Jan 06 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.699 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6516 |
| Theriva Biologics Inc | 0.1902 |
| Oragenics Inc | 3.015 |
Price to Book Value Related Metrics
| PS Ratio | 0.3137 |
| Price | 11.93 |
| Earnings Yield | -187.8% |
| Market Cap | 14.75M |